Japanese prosthetics and orthotics company Instalimb has secured new funding from Orthomos Investment, reinforcing investor interest in digital manufacturing models that use AI, 3D-CAD and 3D printing to expand access to prosthetic and orthotic care. The development was reported by The Bridge on 21 May 2026.
For BharatCPO readers, the news is particularly relevant because Instalimb already operates in India as part of its wider international model. The company describes its platform as an end-to-end digital manufacturing system for prosthetics and orthotics, using remote scanning, a centralised factory model and a traceable digital workflow to deliver sockets and devices more efficiently.
Instalimb’s stated mission is to create a world where everyone who needs prosthetic and orthotic devices can access them. Its model combines 3D-CAD, 3D printing and machine-learning technologies to produce affordable, high-quality devices, with activities listed across Japan, India and the Philippines. The company also states that it has worked with more than 16 partners, operates across more than six countries, and has reached more than 4,000 users globally.
The company’s business model is especially important for countries like India, where demand for prosthetic and orthotic care is large, geographically distributed and often cost-sensitive. Traditional prosthetic fabrication can depend heavily on specialist labour, repeated clinic visits and workshop capacity. Digital workflows may help reduce some of these barriers by capturing patient data more efficiently, standardising design steps and allowing production to be managed through a centralised or distributed manufacturing system.
Instalimb says its platform supports both a clinic business for patients and a solutions business for organisations, indicating that the company is not only selling individual prostheses but also attempting to offer a manufacturing and service model for providers. This distinction matters for India’s O&P ecosystem, where hospitals, NGOs, private clinics, government programmes and charitable limb services may all need scalable ways to deliver consistent prosthetic care.
The funding also adds to a longer pattern of investor support for Instalimb. In 2024, Nippon Express Holdings announced that it had acquired a stake in the company through the NX Global Innovation Fund, noting that Instalimb was expanding its 3D-printed prosthetics business overseas in the Philippines, India and elsewhere. Nippon Express stated that Instalimb manufactured and sold 3D-printed prosthetic legs overseas at around one-tenth the conventional price and with shorter delivery times, and had received positive feedback from more than 2,500 users at that stage.
Another investor profile from JIC Venture Growth Investments describes Instalimb as a company using 3D printing and AI to develop digital manufacturing solutions and provide affordable, high-quality prosthetics and orthotics. It also notes that 3D-printed prosthetic feet are manufactured and sold locally in the Philippines and India, while digital prosthetic manufacturing solutions are licensed to prosthetic footwear manufacturers in other markets, including Ukraine.
For India, the significance of Instalimb’s model lies in three areas: access, affordability and scalability. Many amputees and people requiring orthotic support still face delays, travel costs and limited local service availability. A digital workflow that connects scanning, design, fabrication and delivery could help shorten the pathway between assessment and device provision, especially if linked to trained local clinicians and reliable follow-up.
However, digital manufacturing should not be viewed as a complete replacement for clinical expertise. Prosthetic and orthotic care still requires assessment, prescription, socket fit evaluation, alignment, gait training, user education, follow-up and repair. AI and 3D printing can support the process, but clinical judgement remains essential. For BharatCPO, the key question is not whether technology can make devices faster, but whether it can improve safe, affordable and sustainable care for Indian users.
Instalimb’s India presence also reflects a broader trend: international and domestic companies are increasingly viewing India as a major market for digital O&P innovation. The country’s rehabilitation needs are shaped by road traffic injuries, diabetes, vascular disease, trauma, congenital conditions and uneven access to specialist care. Technologies that reduce production time and support lower-cost fabrication could have a meaningful role if integrated into proper clinical pathways.
The announcement also points to a growing investor belief that prosthetics and orthotics can be transformed through digital infrastructure. In many markets, O&P remains a craft-intensive and highly localised field. Instalimb’s approach suggests a different model: capture clinical data locally, process designs digitally, manufacture through standardised 3D-printing workflows and create repeatable service systems across multiple countries.
For Indian clinicians, this raises practical opportunities and questions. Digital tools may support productivity, documentation and repeatability. They may also help clinics serve more patients with fewer workshop bottlenecks. But implementation must address training, quality assurance, material performance, regulatory compliance, repairability and long-term follow-up.
Key issues for India’s O&P sector include:
- How AI-assisted design can support, rather than replace, prosthetist and orthotist decision-making
- Whether 3D-printed sockets and components can meet long-term durability and safety expectations
- How digital workflows can be integrated into public hospitals, private clinics and NGO limb programmes
- Whether centralised manufacturing can serve rural and semi-urban users without weakening local follow-up
- How cost savings can be passed on to patients
- How digital patient data should be stored, protected and reused for future device replacement
The Instalimb funding news should therefore be seen as part of a wider shift in prosthetic and orthotic care. The future of O&P in India is likely to include a mix of traditional clinical skill, digital capture, AI-assisted modification, 3D printing, centralised production and local rehabilitation support.
For BharatCPO, the important message is that digital O&P is no longer experimental. Companies like Instalimb are attracting capital, building cross-border operations and testing new service models in countries including India. The challenge now is to ensure that innovation translates into better access, better fit, lower cost and stronger long-term outcomes for users.
- Original The Bridge article on Instalimb funding from Orthomos Investment
- Instalimb official website
- Nippon Express Holdings investment announcement for Instalimb
- JIC Venture Growth Investments profile on Instalimb
- Instalimb news page
- World Health Organization standards for prosthetics and orthotics
- International Society for Prosthetics and Orthotics standards resources
- Department of Empowerment of Persons with Disabilities, Government of India